FSLR
47
7
CHD
50
2
GIS
26
-3
ADP
68
-4
V
66
-4
R
75
-2
NOC
34
-6
NTRS
55
-5
MCK
73
-2
MLM
51
-6
ORLY
66
-3
CINF
50
-3
ETR
65
-3
CNP
44
-6
UNH
60
-3
MMC
57
-7
URI
66
-3
XOM
48
-3
KIM
70
-3
TDC
73
2
FSLR
47
7
CHD
50
2
GIS
26
-3
ADP
68
-4
V
66
-4
R
75
-2
NOC
34
-6
NTRS
55
-5
MCK
73
-2
MLM
51
-6
ORLY
66
-3
CINF
50
-3
ETR
65
-3
CNP
44
-6
UNH
60
-3
MMC
57
-7
URI
66
-3
XOM
48
-3
KIM
70
-3
TDC
73
2
Financhill
Back

Lifecore Biomedical Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Sell
39

LFCR
Lifecore Biomedical

Last Price:
6.45
Seasonality Move:
0.9%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Lifecore Biomedical Price Quote

$6.45
-0.23 (-3.44%)
(Updated: November 15, 2024 at 11:55 AM ET)

Lifecore Biomedical Key Stats

Sell
39
Lifecore Biomedical (LFCR) is a Sell
Day range:
$6.55 - $7.13
52-week range:
$3.68 - $8.90
Dividend yield:
0%
P/E ratio:
20.88
P/S ratio:
1.83
P/B ratio:
0%
Volume:
172.1K
Avg. volume:
168K
1-year change:
-12.34%
Market cap:
$246M
Revenue:
$128.3M
EPS:
$0.05

How Much Does Lifecore Biomedical Make?

Is Lifecore Biomedical Growing As A Company?

  • What Is Lifecore Biomedical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.01%
  • What Is Lifecore Biomedical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Lifecore Biomedical Stock Price Performance

What Is Lifecore Biomedical 52-Week High & Low?

Lifecore Biomedical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Lifecore Biomedical?

Is Lifecore Biomedical Cash Flow Positive?

  • What Is LFCR Cash Flow From Operations?
    Cash flow from operations (TTM) is $7.5M
  • What Is Lifecore Biomedical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.7M
  • What Is Lifecore Biomedical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$16.3M

Lifecore Biomedical Return On Invested Capital

  • Is Management Doing A Good Job?
    LFCR return on invested capital is 5.48%
  • What Is Lifecore Biomedical Return On Assets?
    ROA measures how assets are converting to revenues and is 2.64%
  • What Is LFCR Return On Equity?
    ROE is a measure of profitability and is 252.9%

Lifecore Biomedical Earnings Date & Stock Price

Lifecore Biomedical Competitors

  • Who Are Lifecore Biomedical's Competitors?
    Below is a list of companies who compete with Lifecore Biomedical or are related in some way:
    • AngioDynamics Inc (ANGO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Outset Medical Inc (OM)
    • Precision Optics Corp Inc (POCI)
    • Sage Therapeutics Inc (SAGE)

Lifecore Biomedical Dividend Yield

Lifecore Biomedical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 19.51%
Revenue: 0.75% 6.54%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 7.00
Upside from Last Price: 4.79%

Major Shareholders

  • How many LFCR shares are owned by institutional investors?
    29.1M LFCR shares are owned by institutional investors
  • How many LFCR shares are owned by insiders?
    3.4M LFCR shares are owned by insiders